The competing risks Cox model with auxiliary case covariates under weaker missing-at-random cause of failure
Tóm tắt
In the analysis of time-to-event data with multiple causes using a competing risks Cox model, often the cause of failure is unknown for some of the cases. The probability of a missing cause is typically assumed to be independent of the cause given the time of the event and covariates measured before the event occurred. In practice, however, the underlying missing-at-random assumption does not necessarily hold. Motivated by colorectal cancer molecular pathological epidemiology analysis, we develop a method to conduct valid analysis when additional auxiliary variables are available for cases only. We consider a weaker missing-at-random assumption, with missing pattern depending on the observed quantities, which include the auxiliary covariates. We use an informative likelihood approach that will yield consistent estimates even when the underlying model for missing cause of failure is misspecified. The superiority of our method over naive methods in finite samples is demonstrated by simulation study results. We illustrate the use of our method in an analysis of colorectal cancer data from the Nurses’ Health Study cohort, where, apparently, the traditional missing-at-random assumption fails to hold.
Tài liệu tham khảo
Bakoyannis G, Siannis F, Touloumi G (2010) Modelling competing risks data with missing cause of failure. Stat Med 29(30):3172–3185
Basu S, Sen A, Banerjee M (2003) Bayesian analysis of competing risks with partially masked cause of failure. J R Stat Soc Ser C (Appl Stat) 52(1):77–93
Begg CB, Zabor EC, Bernstein JL, Bernstein L, Press MF, Seshan VE (2013) A conceptual and methodological framework for investigating etiologic heterogeneity. Stat Med 32(29):5039–5052
Campbell PT, Jacobs ET, Ulrich CM, Figueiredo JC, Poynter JN, McLaughlin JR, Haile RW, Jacobs EJ, Newcomb PA, Potter JD et al (2010) Case–control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status. J Natl Cancer Inst 102(6):391–400
Cancer Genome Atlas Network (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature 487(7407):330–337
Chatterjee N, Sinha S, Diver WR, Feigelson HS (2010) Analysis of cohort studies with multivariate and partially observed disease classification data. Biometrika 97(3):683–698
Colussi D, Brandi G, Bazzoli F, Ricciardiello L (2013) Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention. Int J Mol Sci 14(8):16,365–16,385
Cox DR (1972) Regression models and life-tables. J R Stat Soc Ser B (Methodol) 34(2):187–220
Craiu RV, Duchesne T (2004) Inference based on the EM algorithm for the competing risks model with masked causes of failure. Biometrika 91(3):543–558
Dewanji A (1992) A note on a test for competing risks with missing failure type. Biometrika 79(4):855–857
Flehinger BJ, Reiser B, Yashchin E (2002) Parametric modeling for survival with competing risks and masked failure causes. Lifetime Data Anal 8(2):177–203
Gao G, Tsiatis AA (2005) Semiparametric estimators for the regression coefficients in the linear transformation competing risks model with missing cause of failure. Biometrika 92(4):875–891
Goetghebeur E, Ryan L (1995) Analysis of competing risks survival data when some failure types are missing. Biometrika 82(4):821–833
Hughes LA, Williamson EJ, van Engeland M, Jenkins MA, Giles GG, Hopper JL, Southey MC, Young JP, Buchanan DD, Walsh MD et al (2012) Body size and risk for colorectal cancers showing BRAF mutations or microsatellite instability: a pooled analysis. Int J Epidemiol 41(4):1060–1072
Hyun S, Lee J, Sun Y (2012) Proportional hazards model for competing risks data with missing cause of failure. J Stat Plan Inference 142(7):1767–1779
Kalbfleisch JD, Prentice RL (2011) The statistical analysis of failure time data, vol 360. Wiley, New York
Kocarnik JM, Shiovitz S, Phipps AI (2015) Molecular phenotypes of colorectal cancer and potential clinical applications. Gastroenterol Rep 3(4):269–276
Kuipers EJ, Grady WM, Lieberman D, Seufferlein T, Sung JJ, Boelens PG, van de Velde CJH, Watanabe T (2015) Colorectal cancer. Nat Rev Dis Primers 1:15,065 EP. doi:10.1038/nrdp.2015.65
Lu W, Liang Y (2008) Analysis of competing risks data with missing cause of failure under additive hazards model. Stat Sin 18(1):219–234
Lu K, Tsiatis AA (2001) Multiple imputation methods for estimating regression coefficients in the competing risks model with missing cause of failure. Biometrics 57(4):1191–1197
Lu K, Tsiatis AA (2005) Comparison between two partial likelihood approaches for the competing risks model with missing cause of failure. Lifetime Data Anal 11(1):29–40
Moreno-Betancur M, Latouche A (2013) Regression modeling of the cumulative incidence function with missing causes of failure using pseudo-values. Stat Med 32(18):3206–3223
Nevo D, Zucker DM, Tamimi RM, Wang M (2016) Accounting for measurement error in biomarker data and misclassification of subtypes in the analysis of tumor data. Stat Med 35(30):5686–5700
Ogino S, Stampfer M (2010) Lifestyle factors and microsatellite instability in colorectal cancer: the evolving field of molecular pathological epidemiology. J Natl Cancer Inst 102(6):365–367
Ogino S, Chan AT, Fuchs CS, Giovannucci E (2011) Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut 60(3):397–411
Ogino S, Nishihara R, VanderWeele TJ, Wang M, Nishi A, Lochhead P, Qian ZR, Zhang X, Wu K, Nan H et al (2016) The role of molecular pathological epidemiology in the study of neoplastic and non-neoplastic diseases in the era of precision medicine. Epidemiology 27(4):602–611
Prentice RL, Kalbfleisch JD, Peterson AV Jr, Flournoy N, Farewell V, Breslow N (1978) The analysis of failure times in the presence of competing risks. Biometrics 43(4):541–554
Sen A, Banerjee M, Li Y, Noone AM (2010) A Bayesian approach to competing risks analysis with masked cause of death. Stat Med 29(16):1681–1695
Wang M, Kuchiba A, Ogino S (2015) A meta-regression method for studying etiological heterogeneity across disease subtypes classified by multiple biomarkers. Am J Epidemiol 182(3):263–270
Wang M, Spiegelman D, Kuchiba A, Lochhead P, Kim S, Chan AT, Poole EM, Tamimi R, Tworoger SS, Giovannucci E, Rosner B, Ogino S (2016) Statistical methods for studying disease subtype heterogeneity. Stat Med 35(5):782–800. doi:10.1002/sim.6793